The rising tide of seaweed patents
Let’s delve deeper into the many applications relating to seaweed which are sculpting the patent landscape.
Fashion Law London recently hosted a key fashion and AI event in London, covering pertinent topics surrounding fashion and AI including use cases, IP, and commercial, data and legislative considerations in this rapidly evolving landscape.
One of the technologies showcased at this year’s Consumer Electronics Show was smart rings, seen by various commentators as having the potential to compete with and potentially replace smart watches.
Against the backdrop of the hearing at the Court of Appeal in Comptroller-General of Patents, Designs & Trade Marks (appellant) v Emotional Perception AI Ltd (respondent) - held on 14-15 May 2024 - we provide an update on patenting artificial intelligence inventions before the UK Intellectual Property Office.
Let’s delve deeper into the many applications relating to seaweed which are sculpting the patent landscape.
The EU Commission published four proposals for amending the current regime for Supplementary Protection Certificates (SPCs) to enable a centralised examination of national and unitary SPCs. We summarise the proposals and some aspects of concern.
On 30 June 2023 the US District Court for the District of New Jersey ruled in favour of Orexo AB in its patent litigation against Sun in relation to ZUBSOLV® (buprenorphine and naloxone) sublingual tablets (CIII), with the Court ruling that Orexo’s patents are both valid and are infringed by Sun.
The Society of Chemical Industries (SCI) has just launched its manifesto for an Industrial Science & Innovation Strategy.
The House of Lords Sub-Committee on the Protocol on Ireland/Northern Ireland released its report on the Windsor Framework on 25 July 2023. In case you missed it, we summarise below how the Framework will affect the valuable intellectual property rights known as Supplementary Protection Certificates (SPCs) in the UK.
Where traditional chemical synthesis is faltering, however, molecular and synthetic biology is providing solutions.
As 10 blockbuster drug patents expire, do pharma companies need to focus even more on patent term extensions & exclusivity strategy?
Today every business is a digital business. If you don’t believe me, think about the following scenarios:
The stage is set for another referral to the Court of Justice of the EU on the eligibility criteria for Supplementary Protection Certificates for “combination products” - those comprising two or more active ingredients.
We would like to pass our heartiest congratulations to our client, Notpla, who have just won the 2022 Earthshot Prize in the 'Build a Waste-Free World' category.
Anna has just joined Potter Clarkson this summer and Potter Clarkson’s Tom Harding sat down to chat with her at the Nordic Life Science Days conference.
Potter Clarkson are delighted to announce their fourth year as an affiliate partner of the Graphene Engineering Innovation Centre (GEIC) in Manchester.